Literature DB >> 22069266

Enteroviruses and type 1 diabetes.

Steven Tracy1, Kristen M Drescher, Nora M Chapman.   

Abstract

BACKGROUND: Human enteroviruses, which are transmitted via a faecal-oral route, have long been associated with type 1 diabetes onset. Increased hygiene in the 20th century may now be responsible for a decreased chance of enterovirus exposure from an early age onward. Infections with enteroviruses may also be more likely to occur at a later age; the recurrent poliomyelitis epidemics in the 20th century were linked to increased hygiene, consistent with this hypothesis. The association of fewer enterovirus exposures and increased diabetes rates may seem at first non-intuitive but may be explained using a combination of human observations and data from experimental coxsackie B virus infections in nonobese diabetic mice.
METHODS: Network for Pancreatic Organ Donors with Diabetes samples were examined for the presence of detectable enteroviral RNA by RT-PCR.
RESULTS: Viral RNA was not detected.
CONCLUSIONS: A role for enteroviruses in the aetiology of human type 1 diabetes is hard to refute but in order to definitively link enteroviruses in general, and specific viruses in particular, with the disease, pancreas biopsy tissue must become available at the time of disease diagnosis.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22069266     DOI: 10.1002/dmrr.1255

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  11 in total

Review 1.  Infection as a cause of type 1 diabetes?

Authors:  Urs Christen; Christine Bender; Matthias G von Herrath
Journal:  Curr Opin Rheumatol       Date:  2012-07       Impact factor: 5.006

Review 2.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

3.  Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence.

Authors:  Oskar Skog; Karin Klingel; Merja Roivainen; Olle Korsgren
Journal:  Diabetologia       Date:  2019-02-27       Impact factor: 10.122

4.  Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.

Authors:  Nicolas Lévêque; Magali Garcia; Alexis Bouin; Joseph H C Nguyen; Genevieve P Tran; Laurent Andreoletti; Bert L Semler
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 5.  Environmental risk factors for type 1 diabetes.

Authors:  Marian Rewers; Johnny Ludvigsson
Journal:  Lancet       Date:  2016-06-04       Impact factor: 79.321

6.  Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans.

Authors:  Oskar Skog; Sofie Ingvast; Olle Korsgren
Journal:  J Clin Virol       Date:  2014-07-30       Impact factor: 3.168

Review 7.  Luminex and other multiplex high throughput technologies for the identification of, and host response to, environmental triggers of type 1 diabetes.

Authors:  Sharad Purohit; Ashok Sharma; Jin-Xiong She
Journal:  Biomed Res Int       Date:  2015-03-25       Impact factor: 3.411

8.  Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.

Authors:  S Smithee; S Tracy; N M Chapman
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

9.  How do childhood diagnoses of type 1 diabetes cluster in time?

Authors:  Colin R Muirhead; Timothy D Cheetham; Simon Court; Michael Begon; Richard J Q McNally
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

Review 10.  The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings.

Authors:  Alberto Pugliese; Mingder Yang; Irina Kusmarteva; Tiffany Heiple; Francesco Vendrame; Clive Wasserfall; Patrick Rowe; Jayne M Moraski; Suzanne Ball; Les Jebson; Desmond A Schatz; Roberto Gianani; George W Burke; Concepcion Nierras; Teo Staeva; John S Kaddis; Martha Campbell-Thompson; Mark A Atkinson
Journal:  Pediatr Diabetes       Date:  2013-12-10       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.